BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 19696791)

  • 1. Association between polymorphisms in glutathione S-transferase Mu3 and IgG titer levels in serum against Helicobacter pylori.
    Tatemichi M; Iwasaki M; Sasazuki S; Tsugane S
    J Hum Genet; 2009 Oct; 54(10):557-63. PubMed ID: 19696791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nested case-control study using IgG titer against Hp surface antigen.
    Tatemichi M; Sasazuki S; Inoue M; Tsugane S;
    Acta Oncol; 2008; 47(3):360-5. PubMed ID: 18347999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-positive antibody titer against Helicobacter pylori cytotoxin-associated gene A (CagA) may predict future gastric cancer better than simple seropositivity against H. pylori CagA or against H. pylori.
    Suzuki G; Cullings H; Fujiwara S; Hattori N; Matsuura S; Hakoda M; Akahoshi M; Kodama K; Tahara E
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1224-8. PubMed ID: 17548689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of IgG antibody titer against Helicobacter pylori.
    Tatemichi M; Sasazuki S; Inoue M; Tsugane S;
    Helicobacter; 2009 Jun; 14(3):231-6. PubMed ID: 19702853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms of the cancer related gene and Helicobacter pylori infection in Japanese gastric cancer patients. An age and gender matched case-control study.
    Kato S; Onda M; Matsukura N; Tokunaga A; Matsuda N; Yamashita K; Shields PG
    Cancer; 1996 Apr; 77(8 Suppl):1654-61. PubMed ID: 8608558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori infection and gastroesophageal reflux in a population-based study (The HUNT Study).
    Nordenstedt H; Nilsson M; Johnsen R; Lagergren J; Hveem K
    Helicobacter; 2007 Feb; 12(1):16-22. PubMed ID: 17241296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphism in chemokine CCL22 and susceptibility to Helicobacter pylori infection-related gastric carcinoma.
    Wang G; Yu D; Tan W; Zhao D; Wu C; Lin D
    Cancer; 2009 Jun; 115(11):2430-7. PubMed ID: 19298002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori, pepsinogen, and gastric adenocarcinoma in Hawaii.
    Nomura AM; Kolonel LN; Miki K; Stemmermann GN; Wilkens LR; Goodman MT; Perez-Perez GI; Blaser MJ
    J Infect Dis; 2005 Jun; 191(12):2075-81. PubMed ID: 15897993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
    Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A
    Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Could Helicobacter pylori play an important role in axonal type of Guillain-Barré syndrome pathogenesis?
    Ghabaee M; Ghanbarian D; Brujeni GN; Bokaei S; Siavoshi F; Gharibzadeh S
    Clin Neurol Neurosurg; 2010 Apr; 112(3):193-8. PubMed ID: 20018440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxin associated gene A-positive Helicobacter pylori strains in dyspeptic pregnant women.
    Noyan V; Apan TZ; Yucel A; Sagsoz N
    Eur J Obstet Gynecol Reprod Biol; 2004 Oct; 116(2):186-9. PubMed ID: 15358462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease.
    Schumann C; Triantafilou K; Rasche FM; Möricke A; Vogt K; Triantafilou M; Hahn P; Schneider EM; Lepper PM
    Int J Med Microbiol; 2006 Aug; 296(4-5):223-8. PubMed ID: 16600680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum concentrations of Helicobacter pylori IgG and the virulence factor CagA in patients with ischaemic heart disease.
    Jafarzadeh A; Esmaeeli-Nadimi A; Nemati M; Tahmasbi M; Ahmadi P
    East Mediterr Health J; 2010 Oct; 16(10):1039-44. PubMed ID: 21222419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study.
    Anderson LA; Murphy SJ; Johnston BT; Watson RG; Ferguson HR; Bamford KB; Ghazy A; McCarron P; McGuigan J; Reynolds JV; Comber H; Murray LJ
    Gut; 2008 Jun; 57(6):734-9. PubMed ID: 18025067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive evaluation of Helicobacter pylori therapy: role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodies.
    Al-Assi MT; Miki K; Walsh JH; Graham DP; Asaka M; Graham DY
    Am J Gastroenterol; 1999 Sep; 94(9):2367-72. PubMed ID: 10483993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grb2-associated binder 1 (Gab1) genetic polymorphism, Helicobacter pylori infection, and chronic atrophic gastritis among older adults from Germany.
    Gao L; Weck MN; Nieters A; Brenner H
    Mol Carcinog; 2010 Oct; 49(10):869-73. PubMed ID: 20602450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LTA 252GG and GA genotypes are associated with diffuse-type noncardia gastric cancer risk in the Japanese population.
    Suzuki G; Cullings H; Fujiwara S; Matsuura S; Kishi T; Ohishi W; Akahoshi M; Hayashi T; Tahara E
    Helicobacter; 2009 Dec; 14(6):571-9. PubMed ID: 19889075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori and stomach cancer: a case-control study in Venezuela.
    Plummer M; Vivas J; Fauchère JL; Del Giudice G; Peña AS; Ponzetto A; Lopez G; Miki K; Oliver W; Muñoz N
    Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):961-5. PubMed ID: 11008915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
    Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Herrero R; Bernal-Sahagún F; Abdo-Francis JM; Aguirre-García J; Muñoz N; Torres J
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum pepsinogen levels, Helicobacter pylori CagA Status, and cytokine gene polymorphisms associated with gastric premalignant lesions in Costa Rica.
    Con SA; Con-Wong R; Con-Chin GR; Con-Chin VG; Takeuchi H; Valerín AL; Echandi G; Mena F; Brenes F; Yasuda N; Araki K; Sugiura T
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2631-6. PubMed ID: 18086767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.